FEB 24, 2017 8:18 AM PST

Gut microbes talk to the immune system

WRITTEN BY: Kerry Evans

Researchers from Harvard Medical School have reported on the results of a large-scale search for immunomodulatory organisms. Specifically, they analyzed how gut bacteria affect immune cells and gene expression.

 

Gut microbes alter immune cells and gene expression. - Mirror Daily

 

These findings will help researchers design individualized treatments for different diseases based on how the gut microbiome interacts with the immune system. According to study author Dennis Kasper, “we set out to map out interactions between bacteria and the immune system in the hope that this could eventually lead to the development of an apothecary of agents tailored to modulate the immune system selectively and precisely.”

 

The group collected 53 of the most common human gut bacteria and transferred them individually to germ-free mice; these 53 species represented the five dominant phyla of gut bacteria: Bacteroidetes, Firmicutes, Proteobacteria, Actinobacteria, and Fusobacteria. Once the mouse guts were colonized with one of the species, they analyzed how each bacterial species affected immune cells and gene expression.

 

Over one-third of the bacterial species they tested increased the number of plasmacytoid dendritic cells in the colon - by at least two-fold. Plasmacytoid dendritic cells are innate immune cells that help detect pathogens. In contrast, some species - Staphylococcus saprophyticus and Lactobacillus rhamnosus - decreased the number of these immune cells (actually, these mice had virtually no plasmacytoid dendritic cells).

 

With respect to T cells, Fusobacterium varium decreased the number of CD4+ and CD8+ αβT cells.

 

Not only did various species of bacteria alter the populations of certain immune cells, they also altered gene expression. They found that Bacteroides dorei and B. longum both induced innate lymphoid cells in the gut to produce IL-22, a cytokine that helps initiate the innate immune response against bacterial pathogens. However, some bacteria - Acinetobacter lwoffii, Clostridium sordellii, and Veillonella - prevented the production of IL-22.

 

Lastly, certain bacteria altered the production of antimicrobial peptides in the gut. F. varium downregulated the expression of the Reg3 genes. On the other hand, Parabacteroides merdae and Porphyromonas uenonis induced the production of α-defensin, but decreased the expression of Reg3.

 

According to Kasper, “we believe that some microbes may upregulate certain genes to create a more hospitable environment for themselves, while others may downregulate certain ones to create a more hostile one for harmful bacteria.”

 

Sources: Cell, Science Daily, Wikipedia

 

 

 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
MAY 18, 2020
Microbiology
An Antibody Against SARS May Neutralize SARS-CoV-2
MAY 18, 2020
An Antibody Against SARS May Neutralize SARS-CoV-2
SARS-CoV caused an outbreak of SARS in 2003. Samples collected from those patients back then may help us against SARS-Co ...
MAY 27, 2020
Cell & Molecular Biology
A Deeper Understanding of How Some Bacterial Toxins Interact With Cells
MAY 27, 2020
A Deeper Understanding of How Some Bacterial Toxins Interact With Cells
The surfaces of cells are decorated with receptors, and the interactions between receptors and their binding partners ar ...
JUN 04, 2020
Microbiology
The Big Effect of a Small Protein
JUN 04, 2020
The Big Effect of a Small Protein
Sepsis and bacterial meningitis are life-threatening diseases caused by meningococci bacteria.
JUN 09, 2020
Microbiology
Bacteria Will Commit Suicide to Spare Their Colony
JUN 09, 2020
Bacteria Will Commit Suicide to Spare Their Colony
In nature, strains of bacteria usually grow in colonies, and together, they are tougher.
JUN 29, 2020
Microbiology
Childhood Vaccine May Help Prevent Severe COVID-19 Cases
JUN 29, 2020
Childhood Vaccine May Help Prevent Severe COVID-19 Cases
Vaccines that contain live attenuated viruses may be giving people some protection from serious cases of COVID-19 that i ...
JUL 03, 2020
Microbiology
Oxford COVID-19 Vaccine Enters Phase 3 Clinical Trials
JUL 03, 2020
Oxford COVID-19 Vaccine Enters Phase 3 Clinical Trials
Millions of people around the world have been infected with the coronavirus called SARS-CoV-2, which causes COVID-19. Th ...
Loading Comments...